NANX · Nanophase Technologies Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.96M | - | $14.60M | $20.36M | $14.63M | - | $16.87M | $13.05M | $9.87M | - |
| Cost of Revenue | $9.62M | - | $11.23M | $14.48M | $11.24M | - | $10.76M | $9.31M | $6.29M | - |
| Gross Profit | $3.34M | - | $3.37M | $5.88M | $3.38M | - | $6.10M | $3.74M | $3.58M | - |
| R&D | $1.04M | - | $1.08M | $955.0K | $1.02M | - | $970.0K | $864.0K | $910.0K | - |
| SG&A | $2.80M | - | $3.07M | $3.01M | $2.11M | - | $1.93M | $1.83M | $1.56M | - |
| Total Operating Expenses | $13.72M | - | $15.72M | $12.19M | $8.97M | - | - | - | - | - |
| D&A | $313.0K | - | - | - | $226.0K | - | - | - | $234.0K | - |
| Operating Income | ($504.0K) | - | ($781.0K) | $1.91M | $256.0K | - | $3.20M | $1.05M | $1.11M | - |
| Interest Expense | - | - | - | - | $218.0K | - | $153.0K | $191.0K | $218.0K | - |
| Income Tax | - | - | - | $390.0K | - | - | - | - | - | - |
| Net Income | ($766.0K) | - | ($1.12M) | $2.67M | $80.0K | - | $3.04M | $856.0K | $893.0K | - |
| EPS - Basic | ($0.01) | - | ($0.02) | $0.04 | $0.00 | - | $0.04 | $0.02 | $0.02 | - |
| EPS - Diluted | ($0.01) | - | ($0.02) | $0.04 | $0.00 | - | $0.04 | $0.01 | $0.02 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $573.0K | $1.29M | $429.0K | $4.11M | $1.82M | $1.41M | $2.92M | $2.36M | $2.02M | $1.72M |
| Accounts Receivable | $6.38M | $6.84M | $9.71M | $11.05M | $9.09M | $4.87M | $8.73M | $5.93M | $5.23M | $3.47M |
| Inventory | $17.56M | $18.51M | $18.87M | $19.83M | $21.91M | $20.27M | $15.04M | $13.87M | $13.28M | $10.03M |
| Accounts Payable | $4.67M | $4.10M | $4.83M | $6.89M | $9.17M | $9.09M | $6.56M | $5.58M | $6.22M | $6.26M |
| Current Assets | $26.41M | $28.78M | $32.79M | $38.77M | $35.90M | $29.35M | $29.76M | $24.26M | $22.08M | $16.30M |
| Total Assets | $47.79M | $50.05M | $53.99M | $59.96M | $57.02M | $50.00M | $48.05M | $40.85M | $38.50M | $32.88M |
| Current Liabilities | $12.69M | $13.93M | $17.86M | $22.54M | $32.88M | $25.77M | $23.29M | $13.77M | $12.18M | $15.59M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $16.97M | $17.63M | $17.23M | $18.19M | $15.16M | $14.95M | $15.17M | $11.92M | $4.95M | $1.90M |
| Retained Earnings | ($99.40M) | ($98.64M) | ($98.80M) | ($97.68M) | ($100.35M) | ($100.43M) | ($99.87M) | ($102.91M) | ($103.77M) | ($104.66M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.52M | - | - | - | ($7.22M) | - | - | - | ($3.85M) | - |
| Investing Cash Flow | ($528.0K) | - | - | - | $133.0K | - | - | - | ($85.0K) | - |
| Financing Cash Flow | ($1.70M) | - | - | - | $7.50M | - | - | - | $4.24M | - |
| CapEx | - | - | - | - | - | - | - | - | $85.0K | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | ($3.94M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 25.8% | - | 23.1% | 28.9% | 23.1% | - | 36.2% | 28.7% | 36.3% | - |
| Operating margin | -3.9% | - | -5.4% | 9.4% | 1.8% | - | 19.0% | 8.0% | 11.3% | - |
| EBITDA margin | -1.5% | - | - | - | 3.3% | - | - | - | 13.6% | - |
| Net margin | -5.9% | - | -7.7% | 13.1% | 0.5% | - | 18.1% | 6.6% | 9.0% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | -39.9% | - |
| FCF / Net income | - | - | - | - | - | - | - | - | -4.41 | - |
| R&D / Revenue | 8.0% | - | 7.4% | 4.7% | 7.0% | - | 5.8% | 6.6% | 9.2% | - |
| SG&A / Revenue | 21.6% | - | 21.0% | 14.8% | 14.4% | - | 11.5% | 14.0% | 15.8% | - |
| Effective tax rate | - | - | - | 12.8% | - | - | - | - | - | - |
| Return on assets | -1.6% | - | -2.1% | 4.4% | 0.1% | - | 6.3% | 2.1% | 2.3% | - |
| Return on equity | -4.5% | - | -6.5% | 14.7% | 0.5% | - | 20.1% | 7.2% | 18.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.08 | 2.07 | 1.84 | 1.72 | 1.09 | 1.14 | 1.28 | 1.76 | 1.81 | 1.05 |
| Quick ratio | 0.70 | 0.74 | 0.78 | 0.84 | 0.43 | 0.35 | 0.63 | 0.75 | 0.72 | 0.40 |
| Cash ratio | 0.05 | 0.09 | 0.02 | 0.18 | 0.06 | 0.05 | 0.13 | 0.17 | 0.17 | 0.11 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | 1.2x | - | 20.9x | 5.5x | 5.1x | - |
| Equity multiplier | 2.82 | 2.84 | 3.13 | 3.30 | 3.76 | 3.35 | 3.17 | 3.43 | 7.78 | 17.29 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.27 | - | 0.27 | 0.34 | 0.26 | - | 0.35 | 0.32 | 0.26 | - |
| Inventory turnover | 0.55 | - | 0.59 | 0.73 | 0.51 | - | 0.72 | 0.67 | 0.47 | - |
| Days sales outstanding | 180d | - | 243d | 198d | 227d | - | 189d | 166d | 193d | - |
| Days inventory outstanding | 666d | - | 613d | 500d | 711d | - | 510d | 544d | 771d | - |
| Days payable outstanding | 177d | - | 157d | 174d | 298d | - | 223d | 219d | 361d | - |
| Cash conversion cycle | 669d | - | 699d | 524d | 640d | - | 477d | 491d | 603d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -11.4% | - | -13.5% | 56.1% | 48.2% | - | 111.9% | 9.9% | 4.3% | - |
| Revenue CAGR (3y) | 11.1% | - | 14.7% | 22.0% | 21.5% | - | 28.6% | 22.4% | 11.7% | - |
| Revenue CAGR (5y) | 12.9% | - | 30.3% | 36.3% | 29.3% | - | 33.2% | - | - | - |
| Gross profit growth (YoY) | -1.3% | - | -44.8% | 57.1% | -5.5% | - | 298.8% | 1.8% | 66.6% | - |
| Operating income growth (YoY) | - | - | - | 82.4% | -77.0% | - | - | 80.8% | - | - |
| Net income growth (YoY) | - | - | - | 211.6% | -91.0% | - | - | 157.1% | - | - |
| EPS growth (YoY) | - | - | - | 300.0% | - | - | - | 0.0% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | 10.1% | - | - | - |
| EPS CAGR (5y) | - | - | - | 32.0% | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | -390.7% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 11.9% | 18.0% | 13.6% | 52.5% | 206.1% | 685.8% | 285.9% | 131.1% | 7.7% | -66.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$124.13M totalProduct$61.79M · 49.8%
Consumer Products$54.87M · 44.2%
Personal Care Ingredients$6.34M · 5.1%
Advanced Materials$857.0K · 0.7%
Product And Service Other$270.0K · 0.2%
Geographic
$5.17M totalNon Us$5.17M · 100.0%
Peer comparison
Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations
Comparing NANOPHASE TECHNOLOGIES Corp against the 5 most active filers in the same SIC group.